We highly recommend enabling Javascript while using the BlackBoxRX site.


Toxicity in Hepatic Impairment

  • This drug in combination with capecitabine is contraindicated in patients with AST or ALT > 2.5 x ULN or bilirubin >1 x ULN due to increased risk of toxicity and neutropenia related death See Contraindications and Warnings and Precautions.

Patient Counseling Information

Package Inserts


Additional Information

Updated January 2018